Clinical trial
A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients…
NCT00420472 · Hoffmann-La Roche, Industry · Terminated
Key facts
| NCT number | NCT00420472 |
|---|---|
| Title | A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS. |
| Official title | An Open-Label Study to Evaluate the Effect on Quality of Life of Switching Kidney Transplant Patients From Reduced Dose EC-MPS to a Higher Than the Equimolar Dose of CellCept |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | mycophenolate mofetil [CellCept] |
| Start date | Mar 1, 2007 |
| First posted | Jan 11, 2007 |
| Last update posted | Nov 20, 2007 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: